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Background: High-Definition transcranial Direct Current Stimulation (HD-tDCS) allows for
non-invasive neuromodulation using an array of compact (approximately 1 cm2 contact
area) “High-Definition” (HD) electrodes, as compared to conventional tDCS (which uses
two large pads that are approximately 35 cm2). In a previous transcutaneous study, we
developed and validated designs for HD electrodes that reduce discomfort over >20 min
session with 2 mA electrode current.
Objective: The purpose of this study was to investigate the use of a chemical pretreatment
with 6% benzocaine (topical numbing agent) to further reduce subjective discomfort during
transcutaneous stimulation and to allow for better sham controlled studies.
Methods: Pre-treatment with 6% benzocaine was compared with control (no
pretreatment) for 22 min 2 mA of stimulation, with either CCNY-4 or Lectron II
electroconductive gel, for both cathodal and anodal transcutaneous (forearm) stimulation
(eight different combinations).
Results: Results show that for all conditions and polarities tested, stimulation with HD
electrodes is safe and well tolerated and that pretreatment further reduced subjective
discomfort.
Conclusion: Pretreatment with a mild analgesic reduces discomfort during HD-tDCS.
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INTRODUCTION
Transcranial Direct Current Stimulation (tDCS) is an investiga-
tional neuromodulation technique that uses scalp electrodes to
deliver 1–2 mA of direct current for 10–20 min (Guleyupoglu
et al., 2013; Villamar et al., 2013). Whereas conventional tDCS
uses two large pads (approximately 35 cm2 contact area, although
not limited to this size), High-Definition tDCS (HD-tDCS) uses
an array of smaller HD electrodes (approximately 1 cm2 contact
area) to deliver current in a more target specific manner (Datta
et al., 2008, 2009; Dmochowski et al., 2011; Guleyupoglu et al.,
2013). Previously we showed that control over HD electrode
parameters, namely shape, electrode material, and gel, allows
for tolerated stimulation with no lasting skin irritation (Minhas
et al., 2010). Several clinical studies have supported the safety and
tolerability of HD-tDCS (Dundas et al., 2007; Nitsche et al., 2009;
Borckardt et al., 2012; Caparelli-Daquer et al., 2012; Kuo et al.,
2013); in some cases pre-treatment with mild topical anesthetic
containing a low-concentration of benzocaine was used. Here
we directly quantified if pre-treatment with a cream containing
6% benzocaine was effective in reducing discomfort across the
forearm during 22 min of stimulation at 2 mA. The forearm was
used during the investigation as it provides a model that does
not involve unintended direct stimulation of the brain. Though
clinical trials support HD-tDCS as a well-tolerated technique,
approaches to reduce discomfort and tingling during stimulation
may further enhance tolerability and sham reliability.
METHODS
Ten healthy subjects, both male (5) and female (5) with ages
ranging from 18 to 35, participated in this study. Each subject
gave informed consent before being included in this study. This
study was approved by the Institutional Review Board of The
City College of New York. A total of eight different conditions
were tested in this series using combinations of anodal/cathodal
stimulation polarity, CCNY-4/Lectron electroconductive gel, and
control/pretreatment conditions (e.g., anodal stimulation with
CCNY-4 gel and no pretreatment). Each subject underwent
stimulation under all eight conditions in random order and
was blinded to the set-up in regards to anodal/cathodal and
which electrogel was used. Stimulation was administered using
a constant current stimulator (Schneider, Germany or Soterix
Medical Inc. 1 × 1 tDCS, New York, NY); 2 mA of current
was delivered to the forearm for 22 min (20 min stimulation,
2 min post-stimulation), with a 10 s ramp up before stimulation,
and a 10 s ramp down before completion of the stimulation.
Ag/AgCl sintered ring electrodes were used (one active and two
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returns); the active electrode was positioned in the center of
the forearm, and the two returns electrodes were positioned
on the upper and lower forearm at approximately 5 cm apart,
immersed in a high volume of gel—the use of two electrodes with
high contact area resulted in sensation being restricted largely to
the center active electrode; thus stimulation polarity, “anodal”
or “cathodal” is used here in references to the center electrode
polarity. The electrode-skin contact area was either pretreated
with 0.2 ml of 6% benzocaine (Lanacane brand) (and left on
the skin before applying gel and stimulation for approximately
8 min) or was left untreated (control). The sintered Ag-Ag/Cl
electrodes (550025, Ring Electrode Stens Corp.) were held in
place using electrode holders (Soterix Medical, New York, NY,
HD-1) and were immersed in either CCNY-4 (custom made)
or Lectron (Lectron II, Pharmaceutical Innovation Inc., Newark,
NJ, USA). Subjects were asked to rate the discomfort felt, using
a pain scale from 0 to 10 (0 being no pain and 10 being
the worst imaginable pain ever), after stimulation ramped up,
every minute during stimulation and after stimulation ramped
down. Subjects were also asked to describe the sensation that
they were feeling (“burning”, “prickling”, etc.). Subjects were
alerted when stimulation was initiated but not when stimula-
tion terminated. After stimulation was terminated, a period of
1 week was used as a “wash-out” period prior to stimulating
the subject again. To analyze the three independant factors (gel
type, polarity, and whether or not pretreatment was applied)
FIGURE 1 | The anodal and cathodal scores are shown with the average
for each subject and error bars are representative of standard error. From
left to right the conditions shown are: CCNY-4/No Pretreatment (in blue),
CCNY-4/Pretreatment (in red), Lectron/No Pretreatment (in green), and
Lectron/Pretreatment (in purple). There was a significant difference between
the control and pretreatment groups (p = 0.0157).
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in this experiment, a 3-way repeated measures ANOVA was
utilized.
RESULTS
Stimulation was well tolerated across subjects and conditions
(Figure 1). Regardless of polarity and gel type, pretreatment
reduced subject sensitivity to stimulation (p = 0.02, F = 6.12).
Further investigation into the effects of polarity (p = 0.80, F =
0.06) and gel type (p = 0.45, F = 0.58) show no significant differ-
ence on subject sensitivity to stimulation. The interaction effect
between these three factors was also investigated. The interaction
between polarity and gel type did not significantly reduce subject
sensitivity to stimulation (p = 0.16, F = 1.97) as well as the
interaction between polarity and pretreatment (p = 0.96, F <
0.01). The interaction between gel type and pretreatment was
also not significant in the reduction of sensitivity (p = 0.73, F =
0.12). Finally, the interaction between the three factors was not
significant in the reduction of subject sensitivity to stimulation
(p = 0.19, F = 1.74).
DISCUSSION
The motivation behind this study was to reduce the level of
discomfort that the subjects feel during stimulation. In this study,
pretreatment with 6% benzocaine was shown to decrease discom-
fort for subjects during stimulation. Benzocaine was chosen for
this investigation since it is a mild local anesthetic that is typically
used as a pain reliever which could help reduce any discomfort
that subjects may have during stimulation. The most common
sensations felt by subjects were itching, tingling and prickling
however, these sensations were not strictly correlated with the
pain score reported. To assess the role of carrier and also electrode
design, we evaluated the effect of aloe and hydrocortisone on
discomfort. In the experiments we combined anode/cathode and
considered two electrode designs (Tin and Ag/AgCl). In the exper-
iments (n = 8) we observed no effect on discomfort by carrier
for either electrode design (p = 0.18, p = 0.25). Since there was
no observed effect on discomfort by carrier, the control for this
design with no pretreatment was used. However, it is still possible
that there is a placebo effect present.
Current flow distribution and electrochemical changes are
critically dependant on all aspects of electrode design (Dundas
et al., 2007; Minhas et al., 2010; Kronberg and Bikson, 2012;
Caytak et al., 2013). It is important to emphasize that the results
of this study are specific to our validated HD electrode design
(Minhas et al., 2010; Borckardt et al., 2012), and further more
apply only to the dose tested (e.g., up to 22 min, 2 mA, one ses-
sion), such that, as with any treatment, adoption of new electrode
designs, increased stimulation intensity, or repetition warrants
explicit testing. A recent report showed no effect on sensation
using lidocaine, an agent similar to benzocaine, when testing con-
ventional tDCS electrodes—indicating the efficacy of anesthetic
is dependent on electrode design or montage (Guarienti et al.,
2014).
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